Dr. Maloney applies the latest research on immunotherapy treatments when treating his patients for blood cancers.
Lymphoma and myeloma treatments are rapidly evolving, with tumor vaccines and monoclonal antibodies providing new treatment options. These can be properly integrated with consideration of the patient's clinical situation and personal philosophy.
Chronic lymphocytic leukemia, lymphoma, Waldenström macroglobulinemia
- Medical Director, Bezos Family Immunotherapy Clinic at Seattle Cancer Care Alliance
- Member, Clinical Research Division, Fred Hutchinson Cancer Research Center
- Professor of Medicine, Division of Oncology, University of Washington
- PhD: Stanford University, 1991
- MD: Stanford University, Medicine, 1985
- BS: Whitworth College, 1977
- Dr. Maloney was recognized in 2012 and 2016 as a "Top Doctor" in Seattle magazine's annual survey.
David G. Maloney, MD, PhD, is a member in the Clinical Research Division at Fred Hutchinson Cancer Research Center and a professor of medicine in the Division of Oncology at the University of Washington. Dr. Maloney treats patients at Seattle Cancer Care Alliance who have chronic lymphocytic leukemia or lymphoma. He is the medical director of the Bezos Family Immunotherapy Clinic at SCCA.
“Lymphoma and myeloma treatments are rapidly evolving,” says Dr. Maloney. “Tumor vaccines and monoclonal antibodies are providing new treatment options. These can be properly integrated with consideration of the patient's clinical situation and personal philosophy.”
His clinical expertise is with antibodies, vaccines, and bone marrow transplantation for treatment of these malignancies.
“After studying many of the sciences, I was especially interested in biology,” says Dr. Maloney, “which led to medicine. I was fortunate to do research with Dr. Ron Levy at Stanford University in the early use of monoclonal antibodies to treat lymphoma. I wanted to continue this and chose oncology.”
Dr. Maloney grew up in Yakima, Washington and earned a PhD and a medical degree from Stanford University. He joined the University of Washington and Fred Hutchinson Cancer Research Center in 1994 and is happy to be back in the Pacific Northwest.
“I enjoy helping patients deal with cancer,” Dr. Maloney says, “and the research and application of new treatments for chronic lymphocytic leukemia, non-Hodgkin’s lymphoma, and multiple myeloma. In my lifetime, I hope to see continued improvement in cancer treatment.”
When he isn’t caring for his patients, Dr. Maloney likes to spend time with his family, as well as hiking, fishing, and bird watching. He also enjoys wood working and bird photography.